-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2024.
- NEUROONE MEDICAL TECHNOLOGIES Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 26.8M shares, a 47.7% increase year-over-year.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 26.8M shares, a 47.7% increase from 2023.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 18.1M shares, a 13.3% increase from 2022.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 16M shares, a 49.6% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)